These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19815247)

  • 1. Effect of trimerization motifs on quaternary structure, antigenicity, and immunogenicity of a noncleavable HIV-1 gp140 envelope glycoprotein.
    Du SX; Idiart RJ; Mariano EB; Chen H; Jiang P; Xu L; Ostrow KM; Wrin T; Phung P; Binley JM; Petropoulos CJ; Ballantyne JA; Whalen RG
    Virology; 2009 Dec; 395(1):33-44. PubMed ID: 19815247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of rabbits with highly purified, soluble, trimeric human immunodeficiency virus type 1 envelope glycoprotein induces a vigorous B cell response and broadly cross-reactive neutralization.
    Quinnan GV; Onabajo O; Zhang P; Yan L; Mattapallil JJ; Zhang Z; Dong M; Lu M; Montefiori D; LaBranche C; Broder CC
    PLoS One; 2014; 9(5):e98060. PubMed ID: 24846288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein.
    Klasse PJ; Depetris RS; Pejchal R; Julien JP; Khayat R; Lee JH; Marozsan AJ; Cupo A; Cocco N; Korzun J; Yasmeen A; Ward AB; Wilson IA; Sanders RW; Moore JP
    J Virol; 2013 Sep; 87(17):9873-85. PubMed ID: 23824824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
    Castillo-Menendez LR; Witt K; Espy N; Princiotto A; Madani N; Pacheco B; Finzi A; Sodroski J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
    Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
    J Virol; 2017 May; 91(10):. PubMed ID: 28250125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific amino acids in the N-terminus of the gp41 ectodomain contribute to the stabilization of a soluble, cleaved gp140 envelope glycoprotein from human immunodeficiency virus type 1.
    Dey AK; David KB; Klasse PJ; Moore JP
    Virology; 2007 Mar; 360(1):199-208. PubMed ID: 17092531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.
    Kumar R; Ozorowski G; Kumar V; Holden LG; Shrivastava T; Patil S; Deshpande S; Ward AB; Bhattacharya J
    J Biol Chem; 2017 Sep; 292(38):15849-15858. PubMed ID: 28743743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin.
    Yang X; Lee J; Mahony EM; Kwong PD; Wyatt R; Sodroski J
    J Virol; 2002 May; 76(9):4634-42. PubMed ID: 11932429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble mimetics of human immunodeficiency virus type 1 viral spikes produced by replacement of the native trimerization domain with a heterologous trimerization motif: characterization and ligand binding analysis.
    Pancera M; Lebowitz J; Schön A; Zhu P; Freire E; Kwong PD; Roux KH; Sodroski J; Wyatt R
    J Virol; 2005 Aug; 79(15):9954-69. PubMed ID: 16014956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1.
    Kang YK; Andjelic S; Binley JM; Crooks ET; Franti M; Iyer SP; Donovan GP; Dey AK; Zhu P; Roux KH; Durso RJ; Parsons TF; Maddon PJ; Moore JP; Olson WC
    Vaccine; 2009 Aug; 27(37):5120-32. PubMed ID: 19567243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure.
    Kovacs JM; Noeldeke E; Ha HJ; Peng H; Rits-Volloch S; Harrison SC; Chen B
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18542-7. PubMed ID: 25512514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Approach to Produce HIV-1 Envelope Trimers: BOTH CLEAVAGE AND PROPER GLYCOSYLATION ARE ESSENTIAL TO GENERATE AUTHENTIC TRIMERS.
    AlSalmi W; Mahalingam M; Ananthaswamy N; Hamlin C; Flores D; Gao G; Rao VB
    J Biol Chem; 2015 Aug; 290(32):19780-95. PubMed ID: 26088135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
    Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
    J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.
    Beddows S; Franti M; Dey AK; Kirschner M; Iyer SP; Fisch DC; Ketas T; Yuste E; Desrosiers RC; Klasse PJ; Maddon PJ; Olson WC; Moore JP
    Virology; 2007 Apr; 360(2):329-40. PubMed ID: 17126869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenicity and immunogenicity of HIV-1 gp140 with different combinations of glycan mutation and V1/V2 region or V3 crown deletion.
    Fu M; Hu K; Hu H; Ni F; Du T; Shattock RJ; Hu Q
    Vaccine; 2019 Dec; 37(51):7501-7508. PubMed ID: 31564450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates.
    Verkerke HP; Williams JA; Guttman M; Simonich CA; Liang Y; Filipavicius M; Hu SL; Overbaugh J; Lee KK
    J Virol; 2016 Oct; 90(20):9471-82. PubMed ID: 27512064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.
    Ringe RP; Pugach P; Cottrell CA; LaBranche CC; Seabright GE; Ketas TJ; Ozorowski G; Kumar S; Schorcht A; van Gils MJ; Crispin M; Montefiori DC; Wilson IA; Ward AB; Sanders RW; Klasse PJ; Moore JP
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response.
    Shrivastava T; Samal S; Tyagi AK; Goswami S; Kumar N; Ozorowski G; Ward AB; Chakrabarti BK
    Vaccine; 2018 Mar; 36(12):1627-1636. PubMed ID: 29429810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer.
    Zhang P; Gorman J; Geng H; Liu Q; Lin Y; Tsybovsky Y; Go EP; Dey B; Andine T; Kwon A; Patel M; Gururani D; Uddin F; Guzzo C; Cimbro R; Miao H; McKee K; Chuang GY; Martin L; Sironi F; Malnati MS; Desaire H; Berger EA; Mascola JR; Dolan MA; Kwong PD; Lusso P
    Cell Host Microbe; 2018 Jun; 23(6):832-844.e6. PubMed ID: 29902444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.